Most investigators comparing ligand-binding procedures for quantifying estrogen and progestin receptors in human breast cancer with procedures employing monoclonal antibodybased methods have utilized an inappropriate variety of reaction conditions, including the elimination of sodium molybdate in th
โฆ LIBER โฆ
Steroid receptor measurement in breast cancers: Comparison between ligand binding and enzyme-immunoassay in cytosolic and nuclear extracts
โ Scribed by Y.A. Luqmani; L. Temmim; A. Memon; M.A.A. Ali; A.H. Parkar
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- French
- Weight
- 370 KB
- Volume
- 71
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Comparison of sex steroid receptor deter
โ
Resad Pasic; Benjamin Djulbegovic; James L. Wittliff
๐
Article
๐
1990
๐
John Wiley and Sons
๐
English
โ 630 KB
Estrogen and progesterone receptors in b
โ
Antonio Cavaliere; Emilio Bucciarelli; Angelo Sidoni; Giuseppina Bianchi; Nadia
๐
Article
๐
1996
๐
John Wiley and Sons
๐
English
โ 453 KB
๐ 2 views
Evaluation of estrogen (ER) and progesterone (PR) receptor content is now an important procedure in the management of breast cancer patients. Production of monoclonal antibodies to ER and PR has permitted development of an enzyme immunoassay (EIA) and immunocytochemical assay (ICA). This study compa